255 related articles for article (PubMed ID: 8690413)
21. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
[TBL] [Abstract][Full Text] [Related]
22. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration?
Haider S; Saleem S; Shameem S; Ahmed SP; Parveen T; Haleem DJ
Pol J Pharmacol; 2004; 56(1):73-8. PubMed ID: 15047980
[TBL] [Abstract][Full Text] [Related]
23. Role of carnosine in preventing thioacetamide-induced liver injury in the rat.
Mehmetçik G; Ozdemirler G; Koçak-Toker N; Cevikbaş U; Uysal M
Peptides; 2008 Mar; 29(3):425-9. PubMed ID: 18164100
[TBL] [Abstract][Full Text] [Related]
24. Experimental thioacetamide-induced cirrhosis of the liver.
Muñoz Torres E; Paz Bouza JI; López Bravo A; Abad Hernández MM; Carrascal Marino E
Histol Histopathol; 1991 Jan; 6(1):95-100. PubMed ID: 1806061
[TBL] [Abstract][Full Text] [Related]
25. A traditional formula, Chunggan extract, attenuates thioacetamide-induced hepatofibrosis via GSH system in rats.
Kwak KG; Wang JH; Shin JW; Lee DS; Son CG
Hum Exp Toxicol; 2011 Sep; 30(9):1322-32. PubMed ID: 21071552
[TBL] [Abstract][Full Text] [Related]
26. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
27. Antioxidative effect of prostaglandin E2 in thioacetamide-induced liver cirrhosis.
Buko V; Lukivskaya O; Nikitin V; Kuryan A; Dargel R
Exp Toxicol Pathol; 1997 Feb; 49(1-2):141-6. PubMed ID: 9085089
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of endothelial nitric oxide synthase maintains nitric oxide production in the cerebellum of thioacetamide cirrhotic rats.
Hernández R; Martínez-Lara E; Del Moral ML; Blanco S; Cañuelo A; Siles E; Esteban FJ; Pedrosa JA; Peinado MA
Neuroscience; 2004; 126(4):879-87. PubMed ID: 15207323
[TBL] [Abstract][Full Text] [Related]
29. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.
Yeh CN; Maitra A; Lee KF; Jan YY; Chen MF
Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942
[TBL] [Abstract][Full Text] [Related]
30. Persistence of liver cirrhosis in association with proliferation of nonparenchymal cells and altered location of alpha-smooth muscle actin-positive cells.
Kang JS; Morimura K; Salim EI; Wanibuchi H; Yamaguchi S; Fukushima S
Toxicol Pathol; 2005; 33(3):329-35. PubMed ID: 15814362
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models.
Natarajan SK; Thomas S; Ramamoorthy P; Basivireddy J; Pulimood AB; Ramachandran A; Balasubramanian KA
J Gastroenterol Hepatol; 2006 Jun; 21(6):947-57. PubMed ID: 16724977
[TBL] [Abstract][Full Text] [Related]
32. The antifibrogenic effect of etanercept on development of liver cirrhosis induced by thioacetamide in rats.
Abdul-Hamid M; Ahmed RR; Moustafa N; Nady R
Ultrastruct Pathol; 2017; 41(1):23-35. PubMed ID: 27982723
[TBL] [Abstract][Full Text] [Related]
33. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
[TBL] [Abstract][Full Text] [Related]
34. The effect of portocaval shunt on bile flow and maximal biliary excretion of bromsulfophthalein sodium (BSP) in rats with thioacetamide induced liver cirrhosis.
Bodnár A; Karácsonyi S; Zsigmond G
Z Exp Chir; 1981 Feb; 14(1):35-9. PubMed ID: 7234017
[TBL] [Abstract][Full Text] [Related]
35. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3.
Wijesundera KK; Izawa T; Tennakoon AH; Murakami H; Golbar HM; Katou-Ichikawa C; Tanaka M; Kuwamura M; Yamate J
Exp Mol Pathol; 2014 Jun; 96(3):382-92. PubMed ID: 24747241
[TBL] [Abstract][Full Text] [Related]
36. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
[TBL] [Abstract][Full Text] [Related]
37. Co-administration of C-Phycocyanin ameliorates thioacetamide-induced hepatic encephalopathy in Wistar rats.
Sathyasaikumar KV; Swapna I; Reddy PV; Murthy ChR; Roy KR; Dutta Gupta A; Senthilkumaran B; Reddanna P
J Neurol Sci; 2007 Jan; 252(1):67-75. PubMed ID: 17169376
[TBL] [Abstract][Full Text] [Related]
38. Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity.
Kang JS; Wanibuchi H; Morimura K; Wongpoomchai R; Chusiri Y; Gonzalez FJ; Fukushima S
Toxicol Appl Pharmacol; 2008 May; 228(3):295-300. PubMed ID: 18374380
[TBL] [Abstract][Full Text] [Related]
39. Resistance of erythrocytes to lipid peroxidation in cirrhotic rats.
Oztezcan S; Balkan J; Dogru-Abbasoglu S; Cevikbas U; Aykaç-Toker G; Uysal M
Arch Med Res; 2005; 36(5):459-63. PubMed ID: 16099321
[TBL] [Abstract][Full Text] [Related]
40. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
